A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in ...

Discover the challenges of treating resistant vaginal thrush and the rise of non-albicans Candida species. Learn about new ...

A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in the prevalence of fungal ...

The treatment ... concentration of fluconazole necessary for a therapeutic effect is not yet known, the study demonstrates that concentrations known to be effective against Candida spp.

Candida is one of the most common causes of nosocomial bloodstream infections. Candidemia is not confined to hematological patients, intensive care units or abdominal surgery wards, but it is ...

Effective from January 1, 2001, standard fluconazole prophylaxis for all ... which allow for rapid Candida albicans identification through the blue staining of the colonies after 48 hours ...

Global fungal infections, which affect 1 billion people and cause 1.5 million deaths each year, are on the rise due to the ...

The drug-resistant fungus, Candida auris, was only discovered 10 ... auris is often mistaken for a different infection, leading to the wrong treatment being given. This means that the patient ...

And we label patients as treatment-resistant if our efforts persistently fail. Yet, all of these ideas hide an inconvenient and disabling truth: Sometimes, we just aren't that capable when we ...

To prevent future antifungal resistance, scientists have developed tiny molecular drills. Candida auris is a relatively new addition to a family of fungi that can infect people. Most of these ...